Global Rofecoxib 麻豆原创 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

Publication ID:

GIR062403042

Publication Date:

June 6, 2024

Pages:

Publisher:

GIR

Countries:

Global [1]

USD 3,480.00

Pharmaceutical Manufacturing [2]

Healthcare [3]

Pharma & Healthcare [4]

Description:

The global Rofecoxib market size was valued at USD million in 2023 and is forecast to a readjusted size of USD million by 2030 with a CAGR of % during review period.
Rofecoxib is a COX-2 selective nonsteroidal anti-inflammatory drug (NSAID). It was marketed by Merck & Co. to treat osteoarthritis, rheumatoid arthritis, juvenile rheumatoid arthritis, acute pain conditions, migraine, and dysmenorrhea.Rofecoxib was available by prescription in both tablet-form and as an oral suspension.
The report includes an overview of the development of the Rofecoxib industry chain, the market status of Osteoarthritis (Oral Suspension., Tablet-Form), Rheumatoid Arthritis (Oral Suspension., Tablet-Form), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Rofecoxib.
Regionally, the report analyzes the Rofecoxib markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Rofecoxib market, with robust domestic demand, supportive policies, and a strong manufacturing base.
Key Features:
The report presents comprehensive understanding of the Rofecoxib market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Rofecoxib industry.
The report involves analyzing the market at a macro level:
麻豆原创 Sizing and Segmentation: Report collect data on the overall market size, including the sales quantity (K Units), revenue generated, and market share of different by Type (e.g., Oral Suspension., Tablet-Form).
Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Rofecoxib market.
Regional Analysis: The report involves examining the Rofecoxib market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
麻豆原创 Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Rofecoxib market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
The report also involves a more granular approach to Rofecoxib:
Company Analysis: Report covers individual Rofecoxib manufacturers, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Rofecoxib This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Osteoarthritis, Rheumatoid Arthritis).
Technology Analysis: Report covers specific technologies relevant to Rofecoxib. It assesses the current state, advancements, and potential future developments in Rofecoxib areas.
Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Rofecoxib market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
麻豆原创 Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
麻豆原创 Segmentation
Rofecoxib market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
麻豆原创 segment by Type
Oral Suspension.
Tablet-Form
麻豆原创 segment by Application
Osteoarthritis
Rheumatoid Arthritis
Juvenile Rheumatoid Arthritis
Acute Pain Conditions
Migraine
Dysmenorrhea
Major players covered
Merck
Chengdu Meinkai Chemical Co. LTD
Wuhan Xinxin Jiali Biotechnology Co. LTD
Hubei TuoChu Kang Yuan Pharmaceutical Chemical Co. LTD
Pfizer
Tremeau
麻豆原创 segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Rofecoxib product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Rofecoxib, with price, sales, revenue and global market share of Rofecoxib from 2019 to 2024.
Chapter 3, the Rofecoxib competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Rofecoxib breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2019 to 2030.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2019 to 2030.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2023.and Rofecoxib market forecast, by regions, type and application, with sales and revenue, from 2025 to 2030.
Chapter 12, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Rofecoxib.
Chapter 14 and 15, to describe Rofecoxib sales channel, distributors, customers, research findings and conclusion.

Please Note - This is an on demand report and will be delivered in 2 business days (48 Hours) post payment.

Table Of Contents:

1 麻豆原创 Overview
1.1 Product Overview and Scope of Rofecoxib
1.2 麻豆原创 Estimation Caveats and Base Year
1.3 麻豆原创 Analysis by Type
1.3.1 Overview: Global Rofecoxib Consumption Value by Type: 2019 Versus 2023 Versus 2030
1.3.2 Oral Suspension.
1.3.3 Tablet-Form
1.4 麻豆原创 Analysis by Application
1.4.1 Overview: Global Rofecoxib Consumption Value by Application: 2019 Versus 2023 Versus 2030
1.4.2 Osteoarthritis
1.4.3 Rheumatoid Arthritis
1.4.4 Juvenile Rheumatoid Arthritis
1.4.5 Acute Pain Conditions
1.4.6 Migraine
1.4.7 Dysmenorrhea
1.5 Global Rofecoxib 麻豆原创 Size & Forecast
1.5.1 Global Rofecoxib Consumption Value (2019 & 2023 & 2030)
1.5.2 Global Rofecoxib Sales Quantity (2019-2030)
1.5.3 Global Rofecoxib Average Price (2019-2030)
2 Manufacturers Profiles
2.1 Merck
2.1.1 Merck Details
2.1.2 Merck Major Business
2.1.3 Merck Rofecoxib Product and Services
2.1.4 Merck Rofecoxib Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.1.5 Merck Recent Developments/Updates
2.2 Chengdu Meinkai Chemical Co. LTD
2.2.1 Chengdu Meinkai Chemical Co. LTD Details
2.2.2 Chengdu Meinkai Chemical Co. LTD Major Business
2.2.3 Chengdu Meinkai Chemical Co. LTD Rofecoxib Product and Services
2.2.4 Chengdu Meinkai Chemical Co. LTD Rofecoxib Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.2.5 Chengdu Meinkai Chemical Co. LTD Recent Developments/Updates
2.3 Wuhan Xinxin Jiali Biotechnology Co. LTD
2.3.1 Wuhan Xinxin Jiali Biotechnology Co. LTD Details
2.3.2 Wuhan Xinxin Jiali Biotechnology Co. LTD Major Business
2.3.3 Wuhan Xinxin Jiali Biotechnology Co. LTD Rofecoxib Product and Services
2.3.4 Wuhan Xinxin Jiali Biotechnology Co. LTD Rofecoxib Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.3.5 Wuhan Xinxin Jiali Biotechnology Co. LTD Recent Developments/Updates
2.4 Hubei TuoChu Kang Yuan Pharmaceutical Chemical Co. LTD
2.4.1 Hubei TuoChu Kang Yuan Pharmaceutical Chemical Co. LTD Details
2.4.2 Hubei TuoChu Kang Yuan Pharmaceutical Chemical Co. LTD Major Business
2.4.3 Hubei TuoChu Kang Yuan Pharmaceutical Chemical Co. LTD Rofecoxib Product and Services
2.4.4 Hubei TuoChu Kang Yuan Pharmaceutical Chemical Co. LTD Rofecoxib Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.4.5 Hubei TuoChu Kang Yuan Pharmaceutical Chemical Co. LTD Recent Developments/Updates
2.5 Pfizer
2.5.1 Pfizer Details
2.5.2 Pfizer Major Business
2.5.3 Pfizer Rofecoxib Product and Services
2.5.4 Pfizer Rofecoxib Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.5.5 Pfizer Recent Developments/Updates
2.6 Tremeau
2.6.1 Tremeau Details
2.6.2 Tremeau Major Business
2.6.3 Tremeau Rofecoxib Product and Services
2.6.4 Tremeau Rofecoxib Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.6.5 Tremeau Recent Developments/Updates
3 Competitive Environment: Rofecoxib by Manufacturer
3.1 Global Rofecoxib Sales Quantity by Manufacturer (2019-2024)
3.2 Global Rofecoxib Revenue by Manufacturer (2019-2024)
3.3 Global Rofecoxib Average Price by Manufacturer (2019-2024)
3.4 麻豆原创 Share Analysis (2023)
3.4.1 Producer Shipments of Rofecoxib by Manufacturer Revenue ($MM) and 麻豆原创 Share (%): 2023
3.4.2 Top 3 Rofecoxib Manufacturer 麻豆原创 Share in 2023
3.4.2 Top 6 Rofecoxib Manufacturer 麻豆原创 Share in 2023
3.5 Rofecoxib 麻豆原创: Overall Company Footprint Analysis
3.5.1 Rofecoxib 麻豆原创: Region Footprint
3.5.2 Rofecoxib 麻豆原创: Company Product Type Footprint
3.5.3 Rofecoxib 麻豆原创: Company Product Application Footprint
3.6 New 麻豆原创 Entrants and Barriers to 麻豆原创 Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 Consumption Analysis by Region
4.1 Global Rofecoxib 麻豆原创 Size by Region
4.1.1 Global Rofecoxib Sales Quantity by Region (2019-2030)
4.1.2 Global Rofecoxib Consumption Value by Region (2019-2030)
4.1.3 Global Rofecoxib Average Price by Region (2019-2030)
4.2 North America Rofecoxib Consumption Value (2019-2030)
4.3 Europe Rofecoxib Consumption Value (2019-2030)
4.4 Asia-Pacific Rofecoxib Consumption Value (2019-2030)
4.5 South America Rofecoxib Consumption Value (2019-2030)
4.6 Middle East and Africa Rofecoxib Consumption Value (2019-2030)
5 麻豆原创 Segment by Type
5.1 Global Rofecoxib Sales Quantity by Type (2019-2030)
5.2 Global Rofecoxib Consumption Value by Type (2019-2030)
5.3 Global Rofecoxib Average Price by Type (2019-2030)
6 麻豆原创 Segment by Application
6.1 Global Rofecoxib Sales Quantity by Application (2019-2030)
6.2 Global Rofecoxib Consumption Value by Application (2019-2030)
6.3 Global Rofecoxib Average Price by Application (2019-2030)
7 North America
7.1 North America Rofecoxib Sales Quantity by Type (2019-2030)
7.2 North America Rofecoxib Sales Quantity by Application (2019-2030)
7.3 North America Rofecoxib 麻豆原创 Size by Country
7.3.1 North America Rofecoxib Sales Quantity by Country (2019-2030)
7.3.2 North America Rofecoxib Consumption Value by Country (2019-2030)
7.3.3 United States 麻豆原创 Size and Forecast (2019-2030)
7.3.4 Canada 麻豆原创 Size and Forecast (2019-2030)
7.3.5 Mexico 麻豆原创 Size and Forecast (2019-2030)
8 Europe
8.1 Europe Rofecoxib Sales Quantity by Type (2019-2030)
8.2 Europe Rofecoxib Sales Quantity by Application (2019-2030)
8.3 Europe Rofecoxib 麻豆原创 Size by Country
8.3.1 Europe Rofecoxib Sales Quantity by Country (2019-2030)
8.3.2 Europe Rofecoxib Consumption Value by Country (2019-2030)
8.3.3 Germany 麻豆原创 Size and Forecast (2019-2030)
8.3.4 France 麻豆原创 Size and Forecast (2019-2030)
8.3.5 United Kingdom 麻豆原创 Size and Forecast (2019-2030)
8.3.6 Russia 麻豆原创 Size and Forecast (2019-2030)
8.3.7 Italy 麻豆原创 Size and Forecast (2019-2030)
9 Asia-Pacific
9.1 Asia-Pacific Rofecoxib Sales Quantity by Type (2019-2030)
9.2 Asia-Pacific Rofecoxib Sales Quantity by Application (2019-2030)
9.3 Asia-Pacific Rofecoxib 麻豆原创 Size by Region
9.3.1 Asia-Pacific Rofecoxib Sales Quantity by Region (2019-2030)
9.3.2 Asia-Pacific Rofecoxib Consumption Value by Region (2019-2030)
9.3.3 China 麻豆原创 Size and Forecast (2019-2030)
9.3.4 Japan 麻豆原创 Size and Forecast (2019-2030)
9.3.5 Korea 麻豆原创 Size and Forecast (2019-2030)
9.3.6 India 麻豆原创 Size and Forecast (2019-2030)
9.3.7 Southeast Asia 麻豆原创 Size and Forecast (2019-2030)
9.3.8 Australia 麻豆原创 Size and Forecast (2019-2030)
10 South America
10.1 South America Rofecoxib Sales Quantity by Type (2019-2030)
10.2 South America Rofecoxib Sales Quantity by Application (2019-2030)
10.3 South America Rofecoxib 麻豆原创 Size by Country
10.3.1 South America Rofecoxib Sales Quantity by Country (2019-2030)
10.3.2 South America Rofecoxib Consumption Value by Country (2019-2030)
10.3.3 Brazil 麻豆原创 Size and Forecast (2019-2030)
10.3.4 Argentina 麻豆原创 Size and Forecast (2019-2030)
11 Middle East & Africa
11.1 Middle East & Africa Rofecoxib Sales Quantity by Type (2019-2030)
11.2 Middle East & Africa Rofecoxib Sales Quantity by Application (2019-2030)
11.3 Middle East & Africa Rofecoxib 麻豆原创 Size by Country
11.3.1 Middle East & Africa Rofecoxib Sales Quantity by Country (2019-2030)
11.3.2 Middle East & Africa Rofecoxib Consumption Value by Country (2019-2030)
11.3.3 Turkey 麻豆原创 Size and Forecast (2019-2030)
11.3.4 Egypt 麻豆原创 Size and Forecast (2019-2030)
11.3.5 Saudi Arabia 麻豆原创 Size and Forecast (2019-2030)
11.3.6 South Africa 麻豆原创 Size and Forecast (2019-2030)
12 麻豆原创 Dynamics
12.1 Rofecoxib 麻豆原创 Drivers
12.2 Rofecoxib 麻豆原创 Restraints
12.3 Rofecoxib Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
13 Raw Material and Industry Chain
13.1 Raw Material of Rofecoxib and Key Manufacturers
13.2 Manufacturing Costs Percentage of Rofecoxib
13.3 Rofecoxib Production Process
13.4 Rofecoxib Industrial Chain
14 Shipments by Distribution Channel
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Rofecoxib Typical Distributors
14.3 Rofecoxib Typical Customers
15 Research Findings and Conclusion
16 Appendix
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer

Companies Mentioned:

Merck
Chengdu Meinkai Chemical Co. LTD
Wuhan Xinxin Jiali Biotechnology Co. LTD
Hubei TuoChu Kang Yuan Pharmaceutical Chemical Co. LTD
Pfizer
Tremeau

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.